![Mark Oki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Oki
Directeur Financier/CFO chez
NEOS THERAPEUTICS, INC.
Fortune : 670 406 $ au 31/05/2026
Profil
Mark K.
Oki is currently Chief Financial Officer at Neos Therapeutics, Inc. and Chief Financial Officer at Achieve Life Sciences, Inc. Formerly, Mr. Oki was Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc. from 2022 to 2024; Chief Financial & Accounting Officer at VIVUS, Inc. from 2015 to 2019; CFO, Secretary & Senior VP-Finance at Alexza Pharmaceuticals, Inc. in 2015; Controller at Pharmacyclics LLC in 2006; and Assistant Controller at Incyte Corp.
from 1998 to 2001.
Education includes an undergraduate degree from San Jose State University conferred in 1991.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/01/2026 | 127 940 ( 0,12 % ) | 670 406 $ | 31/05/2026 |
Postes actifs de Mark Oki
| Sociétés | Poste | Début |
|---|---|---|
| NEOS THERAPEUTICS, INC. | Directeur Financier/CFO | - |
| ACHIEVE LIFE SCIENCES, INC. | Directeur Financier/CFO | 05/12/2024 |
Anciens postes connus de Mark Oki
| Sociétés | Poste | Fin |
|---|---|---|
| AYTU BIOPHARMA, INC. | Directeur Financier/CFO | 11/11/2024 |
| ALEXZA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 16/10/2015 |
| PHARMACYCLICS, INC. | Comptroller/Controller/Auditor | 01/04/2006 |
| INCYTE CORPORATION | Corporate Officer/Principal | 01/01/2001 |
| VIVUS, INC. | Directeur Financier/CFO | - |
Formation de Mark Oki
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
 Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Aytu Biopharma, Inc.
 Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
